Tonka
Well-known member
http://yucatanalamano.com/noticia/nueva-arma-contra-virus-ah1n1-mrida
New weapon against A/H1N1 virus
Published on 2009-12-03
-Federal Health purchased 200 doses of peramivir, two thousand dollars each.
"They anticipate a probable H1N1 resistance to existing drugs
MERIDA .- The Ministry of Health (SSE) said that if necessary Peramivir drug available, treatment which could save the lives of seriously ill patients with influenza A/H1N1.
Yesterday, the Federal Health Secretariat (SSA) reported that it acquired about 200 doses of this treatment, which has a cost of two thousand dollars each.
The director of Prevention and Health Promotion of the SSE, Miguel Betancourt Cravioto, said Mexico is very important that this antiviral has acquired, like any medicine as there are people who have become resistant to oseltamivir and zanamivir, drugs that are used to address virus / HlNl.
"Therefore, the peramivir could be used in these people, especially those who are at risk of death and life saving," he said.
"We know it is very likely that in the coming months or years, the H1N1 virus becomes resistant to zanamivir oseltamilvir or even already been reported cases of patients showing resistance to the antiviral, but these are isolated," he said.
The H5N1 bird flu cases in the last decade and oseltamilvir showed resistance to zanamivir, which is why some laboratories have developed new drugs to replace the existing ones once they start being useless.
"It is thus arises peramivir, which is the last in the treatment of human influenza in severely ill patients," he said.
Betancourt Cravioto explained that the advantage of peramivir is that the virus does not recognize and therefore there is no resistance.
"It is important that the Federal Government to acquire the drug for cases not responding to existing antivirals are treated in time," he said.
The official said that this treatment is very costly, since it is not available in the market and very few doses that are produced, "therefore will be very well protected to not use them indiscriminately to prevent the virus from become resistant.
Source: New Millennium
New weapon against A/H1N1 virus
Published on 2009-12-03
-Federal Health purchased 200 doses of peramivir, two thousand dollars each.
"They anticipate a probable H1N1 resistance to existing drugs
MERIDA .- The Ministry of Health (SSE) said that if necessary Peramivir drug available, treatment which could save the lives of seriously ill patients with influenza A/H1N1.
Yesterday, the Federal Health Secretariat (SSA) reported that it acquired about 200 doses of this treatment, which has a cost of two thousand dollars each.
The director of Prevention and Health Promotion of the SSE, Miguel Betancourt Cravioto, said Mexico is very important that this antiviral has acquired, like any medicine as there are people who have become resistant to oseltamivir and zanamivir, drugs that are used to address virus / HlNl.
"Therefore, the peramivir could be used in these people, especially those who are at risk of death and life saving," he said.
"We know it is very likely that in the coming months or years, the H1N1 virus becomes resistant to zanamivir oseltamilvir or even already been reported cases of patients showing resistance to the antiviral, but these are isolated," he said.
The H5N1 bird flu cases in the last decade and oseltamilvir showed resistance to zanamivir, which is why some laboratories have developed new drugs to replace the existing ones once they start being useless.
"It is thus arises peramivir, which is the last in the treatment of human influenza in severely ill patients," he said.
Betancourt Cravioto explained that the advantage of peramivir is that the virus does not recognize and therefore there is no resistance.
"It is important that the Federal Government to acquire the drug for cases not responding to existing antivirals are treated in time," he said.
The official said that this treatment is very costly, since it is not available in the market and very few doses that are produced, "therefore will be very well protected to not use them indiscriminately to prevent the virus from become resistant.
Source: New Millennium